← Back to Search

Other

Nano-Pulse Stimulation (NPS) Treated Lesion for Skin Abnormalities

N/A
Waitlist Available
Research Sponsored by Pulse Biosciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60-days post-last nps treatment
Awards & highlights

Study Summary

Primary study objective is to evaluate the optimization of Nano-Pulse Stimulation (NPS) energy settings for lesion clearance of Sebaceous Hyperplasia (SH) lesions from facial areas of healthy adult subjects.

Eligible Conditions
  • Skin Abnormalities
  • Sebaceous Hyperplasia
  • Skin Lesions

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60-days post-last nps treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60-days post-last nps treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
SH Lesion Clearance Rate

Trial Design

1Treatment groups
Experimental Treatment
Group I: Nano-Pulse Stimulation (NPS) Treated LesionExperimental Treatment1 Intervention
Nano-Pulse Stimulation of target lesion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nano-Pulse Stimulation (NPS)
2017
N/A
~60

Find a Location

Who is running the clinical trial?

Pulse Biosciences, Inc.Lead Sponsor
9 Previous Clinical Trials
667 Total Patients Enrolled
2 Trials studying Skin Abnormalities
132 Patients Enrolled for Skin Abnormalities
Richard A Nuccitelli, PhDStudy ChairPulse Biosciences, Inc.
2 Previous Clinical Trials
233 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~20 spots leftby Apr 2025